Antineoplastic AgentsRadiation InjuriesRadiation DosageRadiation, IonizingPharmacogeneticsDrug Screening Assays, AntitumorDose-Response Relationship, RadiationCell Line, TumorRadiation ToleranceNeoplasmsRadiotherapyRadiotherapy DosageDoxorubicinDrug Resistance, NeoplasmRadiationCombined Modality TherapyApoptosisRadiation ProtectionRadiation OncologyCell SurvivalCisplatinRadiotherapy, ConformalRadiation MonitoringRadiotherapy, Intensity-ModulatedTumor Cells, CulturedAntineoplastic Agents, PhytogenicDose FractionationT-Lymphocytes, CytotoxicRadiotherapy Planning, Computer-AssistedAntibiotics, AntineoplasticRadiotherapy, AdjuvantRadiation PneumonitisDrug Delivery SystemsDrug ResistanceDrug Resistance, MultipleBreast NeoplasmsMice, NudeDose-Response Relationship, DrugRadiation-Sensitizing AgentsP-GlycoproteinTreatment OutcomeXenograft Model Antitumor AssaysBrachytherapyGamma RaysInhibitory Concentration 50PaclitaxelEtoposideFluorouracilRadiometryCell ProliferationTime FactorsNeoplasms, Radiation-InducedRadiation Injuries, ExperimentalDNA DamageAntineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsIndividualized MedicineDrug CarriersRadiosurgeryLung NeoplasmsDrug SynergismCosmic RadiationAntimetabolites, AntineoplasticDrug DesignGene Expression Regulation, NeoplasticRadiotherapy, Computer-AssistedDaunorubicinProdrugsNeoplasm TransplantationVincristineCamptothecinVinblastineBiomarkers, PharmacologicalCranial IrradiationHead and Neck NeoplasmsProstatic NeoplasmsCell CycleParticle AcceleratorsNeoplasm Recurrence, LocalEllipticinesAdenocarcinomaRadiotherapy, Image-GuidedDrug Evaluation, PreclinicalRadiation-Protective AgentsCell LineEnzyme InhibitorsBackground RadiationAntineoplastic Agents, AlkylatingUltraviolet RaysRadiodermatitisSignal TransductionNeoplasms, ExperimentalClinical Trials as TopicMolecular StructureCarcinoma, Squamous CellMutationPharmaceutical PreparationsRadiotherapy, High-EnergyModels, BiologicalNeoplasm Proteins